Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
Characterization of HPV and host genome interactions in primary head and neck cancersMichael Parfenov, Darlene Lee, Chandra Sekhar Pedamallu et al.|Proceedings of the National Academy of Sciences|2014Cited by 397
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancerKenneth L. Scott, Lynda Chin, Omar Kabbarah et al.|Nature|2009Cited by 353
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J. Hanna, Peter S. Hammerman, Hongye Liu et al.|Oral Oncology|2017Cited by 89
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Cancer Immunology Research|2022Cited by 88